The transition towards proactive and personalized medicine is underway. We focus on next generation platforms combining advanced technologies, financial strategy, and business model innovation to deliver more efficient and equitable health outcomes.
Technological advances have so much potential for health outcomes - but only if we can develop new approaches to align stakeholder interests.
Our Healthcare and Life Sciences Unit runs targeted Innovation Programs that conduct deep research to uncover market challenges and develop system-level solutions with clear economics and established product-market-fit. We ask hard questions and work with a network of stakeholders - from biotech to health insurers - to ensure we engage only the very best opportunities.
What if novel financing structures could unlock a faster, more cost effective drug development process?
Can alternative payment models facilitate equitable access to cutting-edge precision therapies?
How could an open-source ecosystem accelerate the adoption of digital diagnostics & therapeutics?
How can financial and technology innovations align interests for effective value-based care?
Our Healthcare and Life Sciences Unit includes world-class investors and expert advisors committed to partnering with founders dedicated to solving the industries most pressing challenges.
Meet the team
Our team augments a founding team’s capabilities with the expertise and ecosystem to breakthrough barriers and drive success.
Learn moreAccelerating your journey
We pair each investment with a dedicated cobuilding team to reinforce critical capabilities, such as team formation, sales development, capital formation, and more.
Amplifying your reach
We leverage the Braven network to facilitate new commercial opportunities and foster strategic partnerships.
De-risking your path
We work with founders to stress test and optimize a strategy that anticipates obstacles, delivering hands-on support to de-risk execution.
